Strs Ohio reduced its position in shares of Select Medical Holdings Co. (NYSE:SEM) by 8.3% in the second quarter, according to its most recent filing with the SEC. The fund owned 62,600 shares of the health services provider’s stock after selling 5,700 shares during the quarter. Strs Ohio’s holdings in Select Medical were worth $993,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Parallel Advisors LLC boosted its position in shares of Select Medical by 2,889.2% during the 1st quarter. Parallel Advisors LLC now owns 2,481 shares of the health services provider’s stock valued at $35,000 after acquiring an additional 2,398 shares during the last quarter. NumerixS Investment Technologies Inc boosted its position in shares of Select Medical by 21.9% during the 1st quarter. NumerixS Investment Technologies Inc now owns 9,122 shares of the health services provider’s stock valued at $126,000 after acquiring an additional 1,636 shares during the last quarter. Two Sigma Advisers LP bought a new position in shares of Select Medical during the 4th quarter valued at approximately $244,000. BBT Capital Management LLC bought a new position in shares of Select Medical during the 1st quarter valued at approximately $226,000. Finally, Amalgamated Bank bought a new position in shares of Select Medical during the 4th quarter valued at approximately $260,000. Hedge funds and other institutional investors own 75.16% of the company’s stock.
NYSE:SEM opened at $16.10 on Wednesday. The firm’s fifty day moving average is $15.95. Select Medical Holdings Co. has a fifty-two week low of $12.96 and a fifty-two week high of $20.24. The stock has a market cap of $2.17 billion, a price-to-earnings ratio of 15.63, a PEG ratio of 1.06 and a beta of 1.27. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 4.18.
In other Select Medical news, VP Robert G. Breighner, Jr. sold 3,589 shares of the stock in a transaction on Monday, August 5th. The stock was sold at an average price of $15.22, for a total value of $54,624.58. Following the sale, the vice president now owns 33,035 shares in the company, valued at $502,792.70. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Corporate insiders own 19.50% of the company’s stock.
A number of research analysts have recently commented on SEM shares. ValuEngine upgraded Select Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, May 22nd. TheStreet upgraded Select Medical from a “c+” rating to a “b-” rating in a research report on Thursday, June 27th. Barclays reiterated a “hold” rating and set a $16.00 target price on shares of Select Medical in a research report on Thursday, May 9th. Finally, JMP Securities upgraded Select Medical from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a research report on Friday, May 17th. Four analysts have rated the stock with a hold rating and one has issued a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $16.67.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates through four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Recommended Story: What is Considered a Good Return on Equity (ROE)?
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.